Empirical Treatment for Gonorrhea-Positive Sexual Partners

Introduction to Empirical Treatment

The Centers for Disease Control and Prevention (CDC) strongly recommends empirical treatment for sexual partners of gonorrhea-positive patients to prevent reinfection, curtail transmission, and prevent complications such as pelvic inflammatory disease 1, 2, 3

Sexual partners must be treated presumptively for both gonorrhea and chlamydia before test results are available, as co-infection is common and can lead to complications if left untreated 1, 2, 4
The CDC explicitly states that sex partners of patients with N. gonorrhoeae infection should be evaluated and treated for both N. gonorrhoeae and C. trachomatis infections if their last sexual contact was within 60 days before onset of symptoms or diagnosis in the index patient 1, 2, 3

Co-infection with gonorrhea and chlamydia is extremely common, making dual coverage essential for effective treatment 4, 5
Reinfection is the primary cause of treatment failure, emphasizing the critical need for partner treatment to prevent ongoing transmission 1, 2, 3

The CDC recommends treating sexual partners with a dual therapy approach, including ceftriaxone for gonorrhea coverage and doxycycline for chlamydia coverage, to ensure comprehensive treatment 1, 2, 3, 4, 5
Alternative single-dose options, such as azithromycin, can be used if compliance with a 7-day regimen is unlikely 5

All sexual partners within the preceding 60 days of symptom onset or diagnosis should be evaluated and treated to prevent reinfection and ongoing transmission 1, 2, 3, 6
If the last sexual contact was more than 60 days before diagnosis, the most recent sex partner should still be treated 1, 2, 3

Both the index patient and partner must abstain from sexual intercourse until 7 days after therapy initiation and complete symptom resolution to prevent reinfection and ongoing transmission 4, 5
All patients with sexually-transmitted infections should receive testing for other STDs, including syphilis and HIV, to ensure comprehensive care 4, 5

Patient-delivered partner therapy should not be routinely used in men who have sex with men due to the high risk of coexisting undiagnosed STDs or HIV infection, and these partners require in-person clinical evaluation 1, 2, 3
Female partners require special attention, including education on the importance of seeking medical evaluation for possible pelvic inflammatory disease, especially if symptomatic 1, 2, 3